Bone Biologics Corporation (BBLG)
NASDAQ · Healthcare
Bone Biologics Corporation Total Liabilities 2019–2020
Bone Biologics Corporation annual/quarterly total liabilities history from 2019 to 2020. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Bone Biologics Corporation total liabilities for the quarter ending December 31, 2020 were 13.7M, a 15.08% increase year-over-year.
- Bone Biologics Corporation total liabilities for 2020 were 13.7M, a 15.08% increase from 2019.
- Bone Biologics Corporation total liabilities for 2019 were 11.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bone Biologics Corporation Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2020 | $14 |
| 2019 | $12 |
| Bone Biologics Corporation Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2020-12-31 | $14 |
| 2019-12-31 | $12 |
Bone Biologics Corporation Total Liabilities — FAQ
Bone Biologics Corporation (BBLG) total liabilities over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBLG's total liabilities history?
The chart and table above show Bone Biologics Corporation's total liabilities by year and by quarter, including the growth rate.